| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses
|
Hurt, Aeron C
|
|
2004
|
103 |
1-2 |
p. 79-83
5 p.
|
artikel
|
| 2 |
Are influenza surveillance data useful for mapping presentations?
|
Uphoff, H
|
|
2004
|
103 |
1-2 |
p. 35-46
12 p.
|
artikel
|
| 3 |
A “universal” human influenza A vaccine
|
Fiers, W
|
|
2004
|
103 |
1-2 |
p. 173-176
4 p.
|
artikel
|
| 4 |
Current status of live attenuated influenza virus vaccine in the US
|
Belshe, Robert B
|
|
2004
|
103 |
1-2 |
p. 177-185
9 p.
|
artikel
|
| 5 |
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine
|
Stephenson, I
|
|
2004
|
103 |
1-2 |
p. 91-95
5 p.
|
artikel
|
| 6 |
Detection of influenza B in clinical specimens: comparison of high throughput RT-PCR and culture confirmation
|
Cheng, Sheau-Mei
|
|
2004
|
103 |
1-2 |
p. 85-90
6 p.
|
artikel
|
| 7 |
Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments
|
Wit, Emmie de
|
|
2004
|
103 |
1-2 |
p. 155-161
7 p.
|
artikel
|
| 8 |
Epidemiological features of a new strain of the influenza A virus—influenza A (H1N2) circulating in England and its public health implications
|
Goddard, N.L
|
|
2004
|
103 |
1-2 |
p. 53-54
2 p.
|
artikel
|
| 9 |
Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity
|
Chen, Dexiang
|
|
2004
|
103 |
1-2 |
p. 147-153
7 p.
|
artikel
|
| 10 |
Exploring cross-protection between influenza strains by an epidemiological model
|
Lavenu, Audrey
|
|
2004
|
103 |
1-2 |
p. 101-105
5 p.
|
artikel
|
| 11 |
Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs
|
Reeth, Kristien Van
|
|
2004
|
103 |
1-2 |
p. 115-124
10 p.
|
artikel
|
| 12 |
Harmonising the virological surveillance of influenza in Europe: results of an 18-country survey
|
Meerhoff, T.J
|
|
2004
|
103 |
1-2 |
p. 31-33
3 p.
|
artikel
|
| 13 |
Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs
|
Hurt, Aeron C
|
|
2004
|
103 |
1-2 |
p. 205-211
7 p.
|
artikel
|
| 14 |
IFC (EDITORIAL BOARD)
|
|
|
2004
|
103 |
1-2 |
p. IFC-
1 p.
|
artikel
|
| 15 |
Immunogenicity and protective efficacy of influenza vaccination
|
Hannoun, Claude
|
|
2004
|
103 |
1-2 |
p. 133-138
6 p.
|
artikel
|
| 16 |
Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use
|
Hehme, N
|
|
2004
|
103 |
1-2 |
p. 163-171
9 p.
|
artikel
|
| 17 |
Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses
|
Nichol, Kristin L
|
|
2004
|
103 |
1-2 |
p. 3-8
6 p.
|
artikel
|
| 18 |
Influenza-associated acute encephalopathy in Japanese children in 1994–2002
|
Togashi, Takehiro
|
|
2004
|
103 |
1-2 |
p. 75-78
4 p.
|
artikel
|
| 19 |
Live cold-adapted influenza A vaccine produced in Vero cell line
|
Romanova, Julia
|
|
2004
|
103 |
1-2 |
p. 187-193
7 p.
|
artikel
|
| 20 |
Medical economics in the field of influenza—past, present and future
|
Szucs, Thomas D
|
|
2004
|
103 |
1-2 |
p. 25-30
6 p.
|
artikel
|
| 21 |
Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply
|
Medema, Jeroen K
|
|
2004
|
103 |
1-2 |
p. 9-15
7 p.
|
artikel
|
| 22 |
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
|
Gubareva, Larisa V
|
|
2004
|
103 |
1-2 |
p. 199-203
5 p.
|
artikel
|
| 23 |
Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population
|
Webby, R.J
|
|
2004
|
103 |
1-2 |
p. 67-73
7 p.
|
artikel
|
| 24 |
Phylogenetic studies of influenza B viruses isolated in southern Africa: 1998–2001
|
Besselaar, Terry G
|
|
2004
|
103 |
1-2 |
p. 61-66
6 p.
|
artikel
|
| 25 |
Preface
|
Osterhaus, Albert
|
|
2004
|
103 |
1-2 |
p. 1-
1 p.
|
artikel
|
| 26 |
Reassortment and evolution of current human influenza A and B viruses
|
Xu, Xiyan
|
|
2004
|
103 |
1-2 |
p. 55-60
6 p.
|
artikel
|
| 27 |
Recent changes among human influenza viruses
|
Lin, Y.P
|
|
2004
|
103 |
1-2 |
p. 47-52
6 p.
|
artikel
|
| 28 |
RETRACTED: The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses
|
Seo, Sang Heui
|
|
2004
|
103 |
1-2 |
p. 107-113
7 p.
|
artikel
|
| 29 |
Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes
|
Rimmelzwaan, G.F
|
|
2004
|
103 |
1-2 |
p. 97-100
4 p.
|
artikel
|
| 30 |
Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?
|
Beyer, W.E.P
|
|
2004
|
103 |
1-2 |
p. 125-132
8 p.
|
artikel
|
| 31 |
Special Issue Contents Pages
|
|
|
2004
|
103 |
1-2 |
p. vii-viii
nvt p.
|
artikel
|
| 32 |
Special issue title page
|
|
|
2004
|
103 |
1-2 |
p. v-
1 p.
|
artikel
|
| 33 |
Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000–2002 influenza seasons
|
Mungall, Bruce A
|
|
2004
|
103 |
1-2 |
p. 195-197
3 p.
|
artikel
|
| 34 |
The expected number of hospitalisations and beds needed due to pandemic influenza on a regional level in the Netherlands
|
van Genugten, Marianne L.L
|
|
2004
|
103 |
1-2 |
p. 17-23
7 p.
|
artikel
|
| 35 |
Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers
|
de Bruijn, I.A
|
|
2004
|
103 |
1-2 |
p. 139-145
7 p.
|
artikel
|
Tijdschrift beschrijving